Avesthagen, ICMR join to promote biomedical research in India
Avesthagen Limited, India
Pharma
Clinical trial insurance comes to the aid of pharma cos
Clinical trial insurance products are now available in India and are being provided by lots of general insurers, including Bajaj Allianz, ICICI Lombard, Tata AIG, Oriental Insurance and New India Assurance, among others.
TAKE Solutions
TAKE Solutions announced recently that its worldwide business in regulatory document management and electronic submissions software arena is making quick inroads in the Indian market.
Centre carves out new pharma dept
Considering the growth of the Indian pharma industry, the government has finally issued a notification for setting up a separate department of pharmaceuticals. The notification was issued on July 1.
Piramal Healthcare to invest in China
Pirmal Healthcare has said it will invest in manufacturing facilities in China and is looking for acquisitions.
Himalaya Drug gets ready for rural play
Himalaya Drug Company is set for a bigger push into rural markets with the launch of a new strategic business unit (SBU) for expanding into smaller towns and hinterland districts.
Govt to provide INR 100 cr to pharma industry
With a view to promote research and development in the pharmaceutical sector, the government plans to provide soft loans of INR 100 crore to the industry in the current fiscal.
GoM to finalise pharma policy soon
Sixteen months after it was set up, an inter-ministerial group is set to finalise a new pharma policy for the country.
Novartis in record Swiss deal
Pharmaceuticals company Novartis is acquiring a potential US$ 39bn (
Changes in pharma CFOs roles: Ernst & Young survey
A latest Ernst & Young survey of Chief financial officers (CFOs) in the Indian pharmaceutical sector underscores important changes in the role of the CFO and the finance function in driving the success of pharmaceutical companies. Respondents of the India CFO survey envisaged a change in their responsibilities, with an increased focus on serving as business partners and managing growth.
ALERT project looks to ICT for drug safety
A new EU-funded information and communication technology (ICT) project is tackling issues of safety in newly developed drugs. Over the next three and a half years, the ALERT (‘Early detection of adverse drug events by integrative mining of clinical records and biomedical knowledge’) project partners will work on an innovative computer system for a better and faster detection of adverse drug reactions (ADRs).
Pharma RFID market expected to hit US$ 1 trillion by 2020
The market for Radio Frequency Identification, or RFID, applications in pharmaceuticals is conservatively estimated to reach US$ 600 million by 2012 with a compound annual growth rate of 60 percent, according to a new market research study.
Suven Life with Eli Lilly for research
Pharmaceutical firm Suven Life Sciences has signed an agreement with US-based Eli Lilly to collaborate on the pre-clinical research of molecules used in the treatment of Central Nervous System(CNS) disorders.
